Last Updated : July 11, 2023
Details
FilesGeneric Name:
nivolumab
Project Status:
Complete
Therapeutic Area:
Resectable Non-Small Cell Lung Cancer
Manufacturer:
Bristol-Myers Squibb
Brand Name:
Opdivo
Project Line:
Reimbursement Review
Project Number:
PC0303-000
Tumour Type:
Lung
NOC Status at Filing:
Post NOC
Biosimilar:
No
Manufacturer Requested Reimbursement Criteria1:
Neoadjuvant treatment of adult patients with resectable NSCLC (tumours 4cm or node positive) when used in combination with platinum-doublet chemotherapy.
Submission Type:
Initial
Fee Schedule:
Schedule A
Indications:
Neoadjuvant treatment of adult patients with resectable NSCLC (tumours ≥4cm or node positive) when used in combination with platinum-doublet chemotherapy.
Recommendation Type:
Reimburse with clinical criteria and/or conditions
Final Recommendation:
- The requested reimbursement criteria are provided by the applicant and do not necessarily reflect the views of CADTH. Reimbursement criteria from CADTH will be documented in the final recommendation, if applicable.
| Call for patient/clinician input open | August 15, 2022 |
|---|---|
| Call for patient/clinician input closed | October 07, 2022 |
| Clarification: - Patient input submission received from Canadian Cancer Society, Lung Cancer Canada | |
| Submission received | September 13, 2022 |
| Submission accepted | September 27, 2022 |
| Review initiated | September 28, 2022 |
| Draft CADTH review report(s) provided to sponsor for comment | December 15, 2022 |
| Deadline for sponsors comments | January 03, 2023 |
| CADTH review report(s) and responses to comments provided to sponsor | January 26, 2023 |
| Expert committee meeting (initial) | February 08, 2023 |
| Draft recommendation issued to sponsor | February 22, 2023 |
| Draft recommendation posted for stakeholder feedback | March 02, 2023 |
| End of feedback period | March 16, 2023 |
| Final recommendation issued to sponsor and drug plans | March 30, 2023 |
| Final recommendation posted | April 18, 2023 |
| Deadline for sponsor to submit redaction requests on draft CADTH review report(s) | April 14, 2023 |
| CADTH review report(s) posted | July 11, 2023 |
Files
Last Updated : July 11, 2023